Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.04M Sell
11,487
-1,941
-14% -$692K 0.4% 50
2025
Q4
$4.4M Buy
13,428
+16
+0.1% +$5.08K 0.43% 41
2025
Q3
$3.78M Buy
13,412
+595
+5% +$173K 0.39% 46
2025
Q2
$3.58M Buy
12,817
+1,569
+14% +$444K 0.4% 49
2025
Q1
$3.5M Buy
11,248
+999
+10% +$295K 0.42% 46
2024
Q4
$2.67M Sell
10,249
-176
-2% -$52.2K 0.32% 60
2024
Q3
$3.36M Sell
10,425
-1,355
-12% -$443K 0.4% 41
2024
Q2
$3.68M Buy
11,780
+1,728
+17% +$508K 0.48% 33
2024
Q1
$2.86M Buy
10,052
+1,418
+16% +$415K 0.37% 47
2023
Q4
$2.49M Sell
8,634
-1,347
-13% -$367K 0.35% 52
2023
Q3
$2.68M Buy
9,981
+1,370
+16% +$342K 0.42% 46
2023
Q2
$1.91M Buy
8,611
+729
+9% +$169K 0.29% 68
2023
Q1
$1.91M Buy
7,882
+236
+3% +$57.9K 0.31% 62
2022
Q4
$2.01M Sell
7,646
-1,127
-13% -$302K 0.36% 54
2022
Q3
$1.98M Buy
8,773
+660
+8% +$160K 0.39% 45
2022
Q2
$1.97M Buy
8,113
+4,068
+101% +$997K 0.38% 54
2022
Q1
$978K Buy
4,045
+261
+7% +$60K 0.2% 120
2021
Q4
$851K Sell
3,784
-374
-9% -$78.9K 0.17% 135
2021
Q3
$884K Sell
4,158
-235
-5% -$54.1K 0.2% 116
2021
Q2
$1.07M Buy
4,393
+878
+25% +$216K 0.25% 92
2021
Q1
$875K Sell
3,515
-635
-15% -$152K 0.25% 100
2020
Q4
$955K Buy
4,150
+78
+2% +$18K 0.28% 77
2020
Q3
$1.03M Buy
4,072
+9
+0.2% +$2.23K 0.37% 66
2020
Q2
$958K Buy
4,063
+411
+11% +$93.8K 0.38% 66
2020
Q1
$740K Buy
+3,652
New +$798K 0.4% 70

Other funds holding AMGN

Wealth Alliance's AMGN Position: Q1 2026 in Review

Wealth Alliance reduced its Amgen (AMGN) stake by 14% in Q1 2026, selling an estimated $692K and leaving 11,487 shares worth $4.04M. The position accounts for 0.4% of the portfolio, ranked #50.

Wealth Alliance first reported a position in AMGN in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.4M in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wealth Alliance held 11,487 shares of Amgen worth $4.04M as of Q1 2026.
  • Wealth Alliance sold 1,941 Amgen shares in Q1 2026, an estimated $692K.
  • Amgen made up 0.4% of Wealth Alliance's portfolio in Q1 2026, its #50 holding.
  • Wealth Alliance first reported a position in Amgen in Q1 2020 and has held it in 25 quarters since.
  • Wealth Alliance's Amgen position peaked at $4.4M in Q4 2025.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.